-
公开(公告)号:JP2003089639A
公开(公告)日:2003-03-28
申请号:JP2002196850
申请日:2002-07-05
Applicant: SERVIER LAB
Inventor: LANGLOIS MICHEL , MATHE-ALLAINMAT MONIQUE , LEFAS-LE GALL MARIE , BENNEJEAN CAROLINE , RENARD PIERRE , DELAGRANGE PHILIPPE
IPC: C07D339/00 , A61K31/16 , A61K31/165 , A61K31/17 , A61K31/335 , A61K31/343 , A61K31/352 , A61K31/353 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/4355 , A61K31/437 , A61P1/00 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/18 , C07C233/23 , C07C233/74 , C07C235/34 , C07C235/40 , C07C275/26 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/92 , C07D333/58 , C07D333/60 , C07D471/04 , C07D491/04 , C07D491/048 , C07D493/04
Abstract: PROBLEM TO BE SOLVED: To obtain a new cyclic compound having pharmacological action on the receptor for a compound having melatonin-like activity. SOLUTION: This new cyclic compound is expressed by formula (I) [R is ORa , SRa , Ra or a cyclic group; A is a cyclic structure group; G1 and G2 are each an alkylene chain or a single bond; B is NR a C(Q)R a , NR a C(Q)NR a R a or C(Q)NR a R a ; and (p) and (q) are numbers satisfying the formula 1
-
公开(公告)号:NO327076B1
公开(公告)日:2009-04-20
申请号:NO994947
申请日:1999-10-11
Applicant: SERVIER LAB
Inventor: DELAGRANGE PHILIPPE , LANGLOIS MICHEL , MATHE-ALLAINMAT MONIQUE , BENNEJEAN CAROLINE , RENARD PIERRE , GALL MARIE LEFAS-LE
IPC: C07C233/23 , A61K31/16 , C07D339/00 , A61K31/165 , A61K31/17 , A61K31/335 , A61K31/343 , A61K31/352 , A61K31/353 , A61K31/38 , A61K31/381 , A61K31/395 , A61K31/4355 , A61K31/437 , A61P1/00 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/18 , C07C233/74 , C07C235/34 , C07C235/40 , C07C275/26 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/92 , C07D333/58 , C07D333/60 , C07D471/04 , C07D491/04 , C07D491/048 , C07D493/04
Abstract: Cycloalkene substituted cyclic derivatives (I) are new. Cycloalkene substituted cyclic derivatives of formula (I), their enantiomers, diastereoisomers and their acid or base addition salts are new. A = a group of formula (i) or (ii) (optionally substituted by Ra, ORa, OH, CORa, formyl, COORa, COOH or OCORa; Ra = 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, 1-6C polyhaloalkyl, 3-8C cycloalkyl, 3-8C cycloalkyl-(1-6C) alkyl, 3-8C cycloalkenyl, 3-8C cycloalkenyl-(1-6C) alkyl (all optionally substituted with at least one OH, 1-6C alkoxy, 1-6C alkyl, 1-6C polyhaloalkyl, amino or halo), aryl, aryl-(1-6C) alkyl, heteroaryl or heteroaryl-(1-6C) alkyl; X, Y' = O, S or CH2; D' = benzene or naphthalene; a-d = single or double bond; Z = O, S, CH2 or NR ; R = H, 1-6C alkyl, aryl or aryl-(1-6C) alkyl; D'' = benzene or pyridine; R = H, halo, OH, SH, Ra, ORa, S(O)nRa or a (un)saturated 5- to 7-membered ring of formula (iii) (optionally substituted with at least one 1-6C alkyl, 1-6C alkoxy, carboxy, 1-6C alkoxycarbonyl, OH or =O); n = 0-2; E = O or -S(O)n-; G1, G2 = single bond, -(CH2)t- (optionally substituted with at least one OH, COOH, formyl, Ra, ORa, COORa, CORa or halo; p, q = 0-4; p + q = 1-4; B' = -NR aC(Q)R a, -NR aC(Q)NR aR a or -C(Q)NR aR a; R a-R a = H or Ra; Q = O or S; aryl = phenyl, naphthyl, biphenyl (all optionally substituted with at least one OH, 1-6C alkoxy, 1-6C alkyl, 1-6C polyhaloalkyl, CN, COOH, 1-6C alkoxycarbonyl, NO2, amino or halo); heteroaryl = 5- to 10-membered mono- or polycyclic aromatic ring containing 1-3 N, O or S (optionally substituted with at least one OH, 1-6C alkoxy, 1-6C alkyl, 1-6C polyhaloalkyl, CN, COOH, 1-6C alkoxycarbonyl, NO2, amino or halo); and provided that q = 0 and p = 4, or q = 4 and p = 0 do not apply, when A is naphthyl (optionally substituted with methoxy or methyl), G1 and G2 are single bonds and B' is a group of formula (iv) or NHCOCH3; that A is other than halo substituted naphthyl, when G1 is a single bond and p + q is 1; B' is other than urea, when A is indolyl substituted on position 2 with a group of formula (v); and that B' is other than CONH-aryl, when A is indolyl substituted on position 2 with carboxyl or alkoxycarbonyl, p is 1, q is 0 (p is 0 and q is 1) and G1 is single bond. A Independent claim is also included for the preparation of (I).
-
公开(公告)号:DE69933149T2
公开(公告)日:2006-12-21
申请号:DE69933149
申请日:1999-05-10
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , KLUPSCH FREDERIQUE , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LANGLOIS MICHEL , BENNEJEAN CAROLINE , RENARD PIERRE , DELAGRANGE PHILIPPE
IPC: C07C233/36 , C07D295/12 , A61K31/16 , A61K31/165 , A61K31/166 , A61K31/17 , A61K31/18 , A61K31/19 , A61K31/27 , A61K31/341 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/381 , A61K31/382 , A61K31/4025 , A61K31/403 , A61K31/404 , A61K31/4045 , A61K31/405 , A61K31/4184 , A61K31/423 , A61K31/435 , A61K31/4355 , A61K31/436 , A61K31/4365 , A61K31/437 , A61K31/4402 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/4453 , A61K31/453 , A61K31/454 , A61K31/473 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P3/06 , A61P3/10 , A61P5/02 , A61P9/00 , A61P15/08 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/40 , C07C233/43 , C07C233/62 , C07C233/65 , C07C237/48 , C07C271/20 , C07C271/30 , C07C275/24 , C07C275/40 , C07C311/46 , C07C317/32 , C07C323/40 , C07C323/41 , C07C323/44 , C07C323/62 , C07D207/26 , C07D207/27 , C07D209/08 , C07D209/14 , C07D209/16 , C07D209/18 , C07D209/20 , C07D209/60 , C07D209/90 , C07D213/70 , C07D221/08 , C07D221/10 , C07D233/42 , C07D233/84 , C07D235/06 , C07D235/14 , C07D261/20 , C07D295/18 , C07D307/68 , C07D307/77 , C07D307/81 , C07D307/92 , C07D311/58 , C07D311/60 , C07D311/92 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/40 , C07D333/50 , C07D333/56 , C07D333/58 , C07D333/74 , C07D335/06 , C07D335/08 , C07D401/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/12 , C07D409/06 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/048 , C07D491/052 , C07D493/04 , C07D495/04 , C07D495/14 , C07D521/00
Abstract: The invention concerns compounds of formula (I): R-A-R' wherein: A is as defined in the description; R represents a group (V), (VI), (VII) or (VIII), where E, Q, R 1 , R 2 , R 3 , v and R 4 are as defined in the description; R' represents a -(CH 2 )t-R 5 group wherein t and R 5 are as defined in the description.
-
公开(公告)号:FR2857010A1
公开(公告)日:2005-01-07
申请号:FR0307949
申请日:2003-07-01
Applicant: SERVIER LAB
Inventor: LANGLOIS MICHEL , MATHE ALLAINMAT MONIQUE , CHAHED MONCEF AMINE , BOUTIN JEAN ALBERT , AUDINOT VALERIE , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: A61P25/00 , A61P35/00 , C07C233/05 , A61K31/165
Abstract: 1-Acylaminomethyl-4-alkyl-indan or 1-acylaminomethyl-5-alkyl-1,2,3,4-tetrahydronaphthalene derivatives (I) are new. Indane or tetralin derivatives of formula (I) and their enantiomers, diastereomers and acid or base addition salts are new. [Image] R 1>alkyl; R 2>alkyl (optionally substituted by one or more halo), 2-6C alkenyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl; n : 1 or 2; aryl moieties : phenyl, naphthyl or biphenylyl (all optionally substituted by 1-3 of alkyl, alkoxy, OH, COOH, CHO, CN, polyhaloalkyl, alkoxycarbonyl or halo); heteroaryl moieties : mono- or bicyclic aromatic group containing 1-3 of O, S and/or N as heteroatoms (optionally substituted as for aryl); and the alkyl moieties have 1-6C and cycloalkyl moieties 3-8C. An independent claim is included for the preparation of (I). ACTIVITY : Tranquilizer; hypnotic; antidepressant; cardiant; neuroleptic; CNS-Gen.; anorectic; eating disorders-Gen.; anticonvulsant; antidiabetic; antiparkinsonian; nootropic; antimigraine; neuroprotective; cerebroprotective; endocrine-Gen.; vasotropic; cytostatic; antifertility; contraceptive; immunomodulator; analgesic. MECHANISM OF ACTION : Melatonin receptor ligand. (I) have IC 50 values in receptor binding assays for one of the melatoninergic bonding sites (i.e. MT 1, MT 2 or MT 3 receptors); no specific values for individual compounds are given in the source material.
-
公开(公告)号:PT1047664E
公开(公告)日:2004-08-31
申请号:PT98959957
申请日:1998-12-11
Applicant: SERVIER LAB
Inventor: ANDRIEUX JEAN , LANGLOIS MICHEL , ALLAINMAT MONIQUE MATHE , DELAGRANGE PHILIPPE , RENARD PIERRE , BENNEJEAN CAROLINE , JELLIMANN CAROLE
IPC: C07D333/74 , A61K31/165 , A61K31/343 , A61K31/381 , A61K31/403 , A61P9/06 , A61P25/20 , A61P25/22 , A61P43/00 , C07C233/05 , C07C233/18 , C07C233/60 , C07C235/34 , C07C275/24 , C07C275/26 , C07D209/60 , C07D209/90 , C07D307/77 , C07D307/92 , C07D307/93 , C07D333/78
Abstract: The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2)m and (R3)m' are such as defined in the description; n represents an integer such that 0
-
公开(公告)号:AT267163T
公开(公告)日:2004-06-15
申请号:AT98959957
申请日:1998-12-11
Applicant: SERVIER LAB
Inventor: LANGLOIS MICHEL , MATHE-ALLAINMAT MONIQUE , JELLIMANN CAROLE , ANDRIEUX JEAN , BENNEJEAN CAROLINE , RENARD PIERRE , DELAGRANGE PHILIPPE
IPC: C07D333/74 , A61K31/165 , A61K31/343 , A61K31/381 , A61K31/403 , A61P9/06 , A61P25/20 , A61P25/22 , A61P43/00 , C07C233/05 , C07C233/18 , C07C233/60 , C07C235/34 , C07C275/24 , C07C275/26 , C07D209/60 , C07D209/90 , C07D307/77 , C07D307/92 , C07D307/93 , C07D333/78
Abstract: The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2)m and (R3)m' are such as defined in the description; n represents an integer such that 0
-
公开(公告)号:NZ507691A
公开(公告)日:2002-05-31
申请号:NZ50769199
申请日:1999-05-10
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , KLUPSCH FREDERIQUE , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LANGLOIS MICHEL , BENNEJEAN CAROLINE , RENARD PIERRE , DELAGRANGE PHILIPPE
IPC: C07D295/12 , A61K31/16 , A61K31/165 , A61K31/166 , A61K31/17 , A61K31/18 , A61K31/19 , A61K31/27 , A61K31/341 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/381 , A61K31/382 , A61K31/4025 , A61K31/403 , A61K31/404 , A61K31/4045 , A61K31/405 , A61K31/4184 , A61K31/423 , A61K31/435 , A61K31/4355 , A61K31/436 , A61K31/4365 , A61K31/437 , A61K31/4402 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/4453 , A61K31/453 , A61K31/454 , A61K31/473 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P3/06 , A61P3/10 , A61P5/02 , A61P9/00 , A61P15/08 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/36 , C07C233/40 , C07C233/43 , C07C233/62 , C07C233/65 , C07C237/48 , C07C271/20 , C07C271/30 , C07C275/24 , C07C275/40 , C07C311/46 , C07C317/32 , C07C323/40 , C07C323/41 , C07C323/44 , C07C323/62 , C07D207/26 , C07D207/27 , C07D209/08 , C07D209/14 , C07D209/16 , C07D209/18 , C07D209/20 , C07D209/60 , C07D209/90 , C07D213/70 , C07D221/08 , C07D221/10 , C07D233/42 , C07D233/84 , C07D235/06 , C07D235/14 , C07D261/20 , C07D295/18 , C07D307/68 , C07D307/77 , C07D307/81 , C07D307/92 , C07D311/58 , C07D311/60 , C07D311/92 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/40 , C07D333/50 , C07D333/56 , C07D333/58 , C07D333/74 , C07D335/06 , C07D335/08 , C07D401/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/12 , C07D409/06 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/048 , C07D491/052 , C07D493/04 , C07D495/04 , C07D495/14 , C07D521/00
Abstract: A compound of the general formula R-A-R' for use in the treatment of seasonal affective disorder, sleep disorder, cardiovascular pathologies, insomnia and fatigue resulting from jet-lag, appetite disorders and obesity. Wherein; A represents a ring system of Formula (II), (III) or (IV); R represents a group of formula (V) or (VI); and R' represents a group of Formula (VII), wherein R2 represents a group of Formula (VIII).
-
公开(公告)号:AU3610399A
公开(公告)日:1999-11-29
申请号:AU3610399
申请日:1999-05-10
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , KLUPSCH FREDERIQUE , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , LANGLOIS MICHEL , BENNEJEAN CAROLINE , RENARD PIERRE , DELAGRANGE PHILIPPE
IPC: C07D295/12 , A61K31/16 , A61K31/165 , A61K31/166 , A61K31/17 , A61K31/18 , A61K31/19 , A61K31/27 , A61K31/341 , A61K31/343 , A61K31/352 , A61K31/357 , A61K31/381 , A61K31/382 , A61K31/4025 , A61K31/403 , A61K31/404 , A61K31/4045 , A61K31/405 , A61K31/4184 , A61K31/423 , A61K31/435 , A61K31/4355 , A61K31/436 , A61K31/4365 , A61K31/437 , A61K31/4402 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4439 , A61K31/4453 , A61K31/453 , A61K31/454 , A61K31/473 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P3/06 , A61P3/10 , A61P5/02 , A61P9/00 , A61P15/08 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/36 , C07C233/40 , C07C233/43 , C07C233/62 , C07C233/65 , C07C237/48 , C07C271/20 , C07C271/30 , C07C275/24 , C07C275/40 , C07C311/46 , C07C317/32 , C07C323/40 , C07C323/41 , C07C323/44 , C07C323/62 , C07D207/26 , C07D207/27 , C07D209/08 , C07D209/14 , C07D209/16 , C07D209/18 , C07D209/20 , C07D209/60 , C07D209/90 , C07D213/70 , C07D221/08 , C07D221/10 , C07D233/42 , C07D233/84 , C07D235/06 , C07D235/14 , C07D261/20 , C07D295/18 , C07D307/68 , C07D307/77 , C07D307/81 , C07D307/92 , C07D311/58 , C07D311/60 , C07D311/92 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/40 , C07D333/50 , C07D333/56 , C07D333/58 , C07D333/74 , C07D335/06 , C07D335/08 , C07D401/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/12 , C07D409/06 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/048 , C07D491/052 , C07D493/04 , C07D495/04 , C07D495/14 , C07D521/00
Abstract: The invention concerns compounds of formula (I): R-A-R' wherein: A is as defined in the description; R represents a group (V), (VI), (VII) or (VIII), where E, Q, R 1 , R 2 , R 3 , v and R 4 are as defined in the description; R' represents a -(CH 2 )t-R 5 group wherein t and R 5 are as defined in the description.
-
公开(公告)号:AR044975A1
公开(公告)日:2005-10-12
申请号:ARP040102314
申请日:2004-07-01
Applicant: SERVIER LAB
Inventor: LANGLOIS MICHEL , MATHE-ALLAINMAT MONIQUE , CHAHED MONCEF AMINE , BOUTIN JEAN ALBERT , AUDINOT VALERIE , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: A61P25/00 , A61P35/00 , C07C233/05 , C07C233/06 , A61K31/16
Abstract: Compuestos ligandos de receptores de melatonina útiles en el tratamiento de desórdenes del S.N.C.. Reivindicación 1: Compuestos de fórmula (1) caracterizados porque: R1, representa un grupo alquilo C1-6 lineal o ramificado; R2 representa un grupo alquilo C1-6 lineal o ramificado, un grupo alquenilo C2-6 lineal o ramificado, un grupo cicloalquilo C3-8, un grupo cicloalquilo(C3-8)-alquilo(C1-6) donde la parte alquilo puede ser lineal o ramificada, un grupo arilo, un grupo arilo-alquilo(C1-6) donde la parte alquilo puede ser lineal o ramificada, un grupo heteroarilo, un grupo heteroarilo-alquilo(C1-6) donde la parte alquilo puede ser lineal o ramificada, o un grupo alquilo C1-6 lineal o ramificado sustituido por uno o más átomos de halógeno, n es 1 o 2, entendiéndose que: "arilo" indica un grupo fenilo, naftilo o bifenilo; "heteroarilo" indica cualquier grupo aromático mono- bi-cíclico que contiene entre 1 y 3 heteroátomos seleccionados entre O, S y N, donde los grupos arilo y heteroarilo así definidos pueden ser sustituidos por 1 a 3 grupos seleccionados entre alquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, hidroxi, carboxi, formilo, nitro, ciano, polihaloalquilo c1-6 lineal o ramificado, alcoxicarbonilo y átomos de halógeno, sus enantiómeros y diastereoisómeros, y sus sales de adición con un ácido o base farmacéuticamente aceptable.
-
公开(公告)号:SI0994102T1
公开(公告)日:2003-06-30
申请号:SI9930237
申请日:1999-10-12
Applicant: SERVIER LAB
Inventor: LANGLOIS MICHEL , MATHE-ALLAINMAT MONIQUE , LEFAS-LE GALL MARIE , BENNEJEAN CAROLINE , RENARD PIERRE , DELAGRANGE PHILIPPE
IPC: A61K31/16 , A61K31/165 , A61K31/17 , A61K31/335 , A61K31/343 , A61K31/352 , A61K31/353 , A61K31/38 , A61K31/381 , A61K31/395 , C07D339/00 , A61K31/4355 , A61K31/437 , A61P1/00 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/18 , C07C233/23 , C07C233/74 , C07C235/34 , C07C235/40 , C07C275/26 , C07D307/79 , C07D307/80 , C07D307/81 , C07D311/92 , C07D333/58 , C07D333/60 , C07D471/04 , C07D491/04 , C07D491/048 , C07D493/04
Abstract: Cycloalkene substituted cyclic derivatives (I) are new. Cycloalkene substituted cyclic derivatives of formula (I), their enantiomers, diastereoisomers and their acid or base addition salts are new. A = a group of formula (i) or (ii) (optionally substituted by Ra, ORa, OH, CORa, formyl, COORa, COOH or OCORa; Ra = 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, 1-6C polyhaloalkyl, 3-8C cycloalkyl, 3-8C cycloalkyl-(1-6C) alkyl, 3-8C cycloalkenyl, 3-8C cycloalkenyl-(1-6C) alkyl (all optionally substituted with at least one OH, 1-6C alkoxy, 1-6C alkyl, 1-6C polyhaloalkyl, amino or halo), aryl, aryl-(1-6C) alkyl, heteroaryl or heteroaryl-(1-6C) alkyl; X, Y' = O, S or CH2; D' = benzene or naphthalene; a-d = single or double bond; Z = O, S, CH2 or NR ; R = H, 1-6C alkyl, aryl or aryl-(1-6C) alkyl; D'' = benzene or pyridine; R = H, halo, OH, SH, Ra, ORa, S(O)nRa or a (un)saturated 5- to 7-membered ring of formula (iii) (optionally substituted with at least one 1-6C alkyl, 1-6C alkoxy, carboxy, 1-6C alkoxycarbonyl, OH or =O); n = 0-2; E = O or -S(O)n-; G1, G2 = single bond, -(CH2)t- (optionally substituted with at least one OH, COOH, formyl, Ra, ORa, COORa, CORa or halo; p, q = 0-4; p + q = 1-4; B' = -NR aC(Q)R a, -NR aC(Q)NR aR a or -C(Q)NR aR a; R a-R a = H or Ra; Q = O or S; aryl = phenyl, naphthyl, biphenyl (all optionally substituted with at least one OH, 1-6C alkoxy, 1-6C alkyl, 1-6C polyhaloalkyl, CN, COOH, 1-6C alkoxycarbonyl, NO2, amino or halo); heteroaryl = 5- to 10-membered mono- or polycyclic aromatic ring containing 1-3 N, O or S (optionally substituted with at least one OH, 1-6C alkoxy, 1-6C alkyl, 1-6C polyhaloalkyl, CN, COOH, 1-6C alkoxycarbonyl, NO2, amino or halo); and provided that q = 0 and p = 4, or q = 4 and p = 0 do not apply, when A is naphthyl (optionally substituted with methoxy or methyl), G1 and G2 are single bonds and B' is a group of formula (iv) or NHCOCH3; that A is other than halo substituted naphthyl, when G1 is a single bond and p + q is 1; B' is other than urea, when A is indolyl substituted on position 2 with a group of formula (v); and that B' is other than CONH-aryl, when A is indolyl substituted on position 2 with carboxyl or alkoxycarbonyl, p is 1, q is 0 (p is 0 and q is 1) and G1 is single bond. A Independent claim is also included for the preparation of (I).
-
-
-
-
-
-
-
-
-